Q1 2018 United Therapeutics Corp Earnings Call
Conference Call United Therapeutics Corp
United Therapeutics Corp Conference call or earnings call will be held on May 2, 2018 via an 800 number (toll-free). During the earnings conference call's session United Therapeutics Corp will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact United Therapeutics Corp for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening diseases. Our key therapeutic products and product candidates include: º * º Prostacyclin Analogues. Prostacyclin analogues are stable synthetic forms of prostacyclin, an important molecule produced by the body that has powerful effects on blood vessel health and function. Our lead product is Remodulin® (treprostinil) Injection (Remodulin), which is administered subcutaneously (under the skin) or intravenously (in the vein) for the treatment of pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise.Read more Conference Call